Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia

International Journal of Cancer

Volumn 133, Issue 12, 2013, Pages 2864-2871

  Khan, Anis ^a,b   Al Balwi, Mohammed A ^a,c,d   Tanaka, Yasuhito ^b   Hajeer, Ali ^c,d   Sanai, Faisal M ^c   Al Abdulkarim, Ibrahim ^a   Al Ayyar, Latifah ^a   Badri, Motasim ^d   Saudi, Dib ^e   Tamimi, Waleed ^c   Mizokami, Masashi ^b,f   Al Knawy, Bandar ^c  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^d KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^e International Medical Center Konodai Hospital ^*  (Saudi Arabia)

^f Konodai National Medical Center   (Japan)

Author keywords

genotype D; hepatitis B virus; hepatocellular carcinoma; mutational complexes; point mutations; sequence analysis; X gene

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; DNA SEQUENCE; ENHANCER REGION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PHYLOGENY; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SAUDI ARABIA; SEQUENCE ANALYSIS; SEROLOGY; SEX DIFFERENCE; STOP CODON; VIRUS CORE; VIRUS LOAD;

GENOTYPE D; HEPATITIS B VIRUS; HEPATOCELLULAR CARCINOMA; MUTATIONAL COMPLEXES; POINT MUTATIONS; SEQUENCE ANALYSIS; X-GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHILD; ENHANCER ELEMENTS, GENETIC; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; POINT MUTATION; PROMOTER REGIONS, GENETIC; SAUDI ARABIA;

EID: 84885583818     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28307     Document Type: Article

References (39)

1. Liaw YF, Chu CM,. Hepatitis B virus infection. Lancet 2009; 373: 582-92.
2. Bruix J, Sherman M,. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
3. Orito E, Ichida T, Sakugawa H, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 2001; 34: 590-4.
4. Tatematsu K, Tanaka Y, Kurbanov F, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009; 83: 10538-47.
5. Yu H, Yuan Q, Ge SX, et al. Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I". PLoS One 2010; 5: e9297.
6. Chan HL, Hui AY, Wong ML, et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004; 53: 1494-8.
7. Ito K, Tanaka Y, Orito E, et al. T1653 mutation in the Box-α increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Clin Infect Dis 2006; 42: 1-7.
8. Sakamoto T, Tanaka Y, Simonetti J, et al. Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations. J Infect Dis 2007; 196: 1487-92.
9. Lau JY, Wright TL,. Molecular virology and pathogenesis of hepatitis B. Lancet 1993; 342: 1335-40.
10. Tanaka Y, Mukaide M, Orito E, et al. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 2006; 45: 646-53.
11. Chou YC, Yu MW, Wu CF, et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 2008; 57: 91-7.
12. Chen CH, Changchien CS, Lee CM, et al. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan. Int J Cancer 2009; 125: 621-9.
13. Kitab B, Essaid El Feydi A, Afifi R, et al. Variability in the precore and core promoter regions of HBV strains in morocco: characterization and impact on liver disease progression. PLoS One 2012; 7: e42891.
14. Jang JW, Chun JY, Park YM, et al. Mutational complex genotype of the hepatitis B virus X/precore regions as a novel predictive marker for hepatocellular carcinoma. Cancer Sci 2012; 103: 296-304.
15. Chandra PK, Biswas A, Datta S, et al. Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat 2009; 16: 749-56.
16. Yousif M, Kramvis A,. Genotype D of hepatitis B virus and its subgenotypes: an update. Hepatol Res 2013; 43: 355-64.
17. Abdo AA, Al-Jarallah BM, Sanai FM, et al. Hepatitis B genotypes: relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia. World J Gastroenterol 2006; 12: 7019-24.
18. Sanai FM, Helmy A, Bzeizi KI, et al. Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B. J Viral Hepatitis 2011; 18: e217-e225.
19. Veazjalali M, Norder H, Magnius L, et al. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis. J Viral Hepat 2009; 16: 259-64.
20. Sendi H, Mehrab-Mohseni M, Zali MR, et al. T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D. J Gen Virol 2005; 86: 2451-8.
21. Bruix J, Sherman M,. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-2.
22. Abdo AA, Hassanain M, Al Jumah A, et al. Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines. Ann Saudi Med 2012; 32: 174-99.
23. Tanaka Y, Hasegawa I, Kato T, et al. A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology 2004; 40: 747-55.
24. Sugauchi F, Mizokami M, Orito E, et al. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol 2001; 82: 883-92.
25. Shin IT, Tanaka Y, Tateno Y, et al. Development and public release of a comprehensive hepatitis virus database. Hepatol Res 2008; 38: 234-43.
26. Hannachi N, Fredj NB, Bahri O, et al. Molecular analysis of HBV genotypes and subgenotypes in the Central-East region of Tunisia. Virol J 2010; 7: 302.
27. Sunbul M, Sugiyama M, Kurbanov F, et al. Specific mutations of basal core promoter are associated with chronic liver disease in hepatitis B virus subgenotype D1 prevalent in Turkey. Microbiol Immunol 2013; 57: 122-9.
28. Elkady A, Tanaka Y, Kurbanov F, et al. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia. J Gastroenterol Hepatol 2008; 23: 474-81.
29. Sugiyama M, Tanaka Y, Sugauchi F, et al. Hepatitis virus genotype D1 specific mutations affecting viral replication and clinical course of hepatitis B patients. HBV Now in Asia: Single Topic Conference. 2009. 85.
30. Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005; 97: 265-72.
31. Guo X, Jin Y, Qian G, et al. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol 2008; 49: 718-25.
32. Tacke F, Gehrke C, Luedde T, et al. Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants. J Virol 2004; 78: 8524-35.
33. Liang TJ, Hasegawa K, Rimon N, et al. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991; 324: 1705-9.
34. Hasegawa K, Huang JK, Wands JR, et al. Association of hepatitis B viral precore mutations with fulminant hepatitis B in Japan. Virology 1991; 185: 460-3.
35. Kao JH, Chen PJ, Lai MY, et al. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003; 124: 327-34.
36. Fang ZL, Yang J, Ge X, et al. Core promoter mutations (A(1762)T and G(1764)A) and viral genotype in chronic hepatitis B and hepatocellular carcinoma in Guangxi, China. J Med Virol 2002; 68: 33-40.
37. Chu CJ, Keeffe EB, Han SH, et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 2003; 38: 619-28.
38. Fang ZL, Sabin CA, Dong BQ, et al. The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis. J Hepatol 2009; 50: 273-80.
39. Livingston SE, Simonetti JP, Bulkow LR, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 2007; 133: 1452-7.